Skip to main content

FASEB: Put NIH back on track

Gearing up to the president's FY08 budget requests, the US biomedical coalition recommends increases over three years to overcome inflationary losses

Written byTed Agres
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Congress should provide the National Institutes of Health with enough funds in the next budget year to "set the NIH on a three-year track to recoup the losses caused by biomedical research inflation," according to the Federation of American Societies for Experimental Biology (FASEB)'s annual funding report, released today (January 31).The biomedical coalition asked lawmakers to give NIH sufficient funds "to maintain its purchasing power and take advantage of scientific opportunities" in Fiscal 2008, which begins Oct. 1, 2007. "We are in danger of sacrificing our nation's dominance in biomedical research and biotechnology," the FASEB report warns. On Monday (Feb. 5), President Bush will submit the Administration's Fiscal 2008 budget requests to Congress, which has failed to pass budgets for the current 2007 fiscal year for NIH and most other government agencies, leaving them to run at 2006 levels. Today, the House is scheduled to vote on a revised budget resolution that would increase funding for selected agencies. NIH would receive a $620 million (or 2.1 percent) increase beyond the Administration's request to support 500 additional research project grants, 1,500 first-time investigators, and expand funding for high-risk research, according to a congressional summary. The Senate is expected to take up the resolution next week.In a break from previous years, FASEB is not recommending a specific dollar amount or percentage increase for NIH for next year. "We don't have a 2007 starting point and we won't have a current estimate of the biomedical rate of inflation until after the president's budget is released," explained Howard Garrison, FASEB's public affairs director. "So both our starting point and target are unidentified due to circumstances beyond our control," he told The Scientist. The funding report represents consensus recommendations of FASEB's 21 biomedical research societies, Garrison said. Last year, FASEB recommended NIH receive a 5 percent increase, and 10 percent the year before that. However, NIH funding since 2004 has remained relatively flat, at around $28 billion. If the NIH budget is maintained at the 2006 level of $28.6 billion for another year, the agency will have lost more than nine percent of its inflation-adjusted purchasing power over the past four years, said Dave Moore, senior associate vice president at the Association of American Medical Colleges (AAMC). "For a program like NIH, this has potentially dramatic effects. That means fewer grants, it means smaller grants, it means it's going to be more difficult for new investigators and young investigators to get their research funded," Moore told The Scientist. Despite the fact that Congress has not heeded FASEB's advice in recent years, "congressional committee staffers are appreciative of FASEB's recommendations because it gives them an idea of what the research community is thinking," noted Garrison. "We try to find ways to represent our membership and the message they want to express" to Congress and the White House.Last month, NIH eliminated a planned 3.4 percent inflationary increase for noncompeting research project grants in 2007 to help fund new and competing RPGs and keep them from dropping below 2005 levels. "We want to address core areas of vulnerability -- new investigators and their ability to compete in these really difficult times," Norka Ruiz Bravo, NIH deputy director for extramural research, told The Scientist. The National Institutes of Health Reform Act of 2006, a non-binding law enacted last month, authorizes -- but does not require -- a 7 percent budget increase of $2 billion for Fiscal 2007 and an 8.2 percent increase of $2.5 billion for Fiscal 2008. Ted Agres tagres@the-scientist.com Links within this article "Federal Funding for Biomedical and Related Life Sciences Research FY 2008," Federation of American Societies for Experimental Biology, Washington, D.C., Jan. 31, 2007 https://opa.faseb.org/pdf/final_funding_fy2008.pdfFederation of American Societies for Experimental Biology (FASEB) https://www.faseb.orgT. Agres, "Science bills hatch from lame duck," The Scientist, Dec. 12, 2006 https://www.the-scientist.com/news/display/37513Revised Continuing Appropriations Resolution, 2007 (HJ Res 20) https://thomas.loc.gov/cgi-bin/query/z?c110:H.J.RES.20:T. Agres, "NIH held to flat funding in '07," The Scientist, February 7, 2006 https://www.the-scientist.com/news/display/23092Summary of the Joint Resolution, House Committee on Appropriations https://appropriations.house.gov/pdf/CRSummary.pdfBiomedical Research and Development Price Index https://officeofbudget.od.nih.gov/PDF/BRDPI_Proj_Revised_July_2006v3.pdfT. Agres, "FASEB recommends 5% NIH boost," The Scientist, Jan. 23, 2006 https://www.the-scientist.com/news/display/23003NIH Fiscal Policy for Grant Awards - FY 2007 https://grants2.nih.gov/grants/guide/notice-files/NOT-OD-07-030.html"National Institutes of Health Reform Act of 2006" (PL 109-482) https://thomas.loc.gov/cgi-bin/cpquery/R?cp109:FLD010:@1(hr687):
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation